New thiazolidinedione reduced the risk of cardiovascular complications in type 2 diabetes
The thiazolidinedione drug, lobeglitazone, reduces the risk of cardiovascular complications in patients with type 2 diabetes and ischemic stroke on par with pioglitazone
17.05.2023